Our research impact: PARP inhibitors 12 May 2022 To mark our outstanding success in REF2021, Alison Halliday spoke to several of our researchers here at the ICR who were instrumental in the development of PARP inhibitors, a type of targeted drug that’s been approved for use in breast, ovarian and prostate cancer. Find out more Show/Hide
From bench to bedside and beyond: the team of scientists that transformed breast cancer treatment 13 Apr 2022 A group of researchers from The Institute of Cancer Research and The Royal Marsden have won the prestigious AACR Team Science Award for breast cancer research. Hear from the winning team about their pioneering work and its impact. Find out more Show/Hide
Scientific achievements of 2020/2021 10 Dec 2021 We've selected a range of discoveries from the academic year that highlight the quality and breadth of our basic, translational and clinical research. Find out more Show/Hide